Page last updated: 2024-10-16

carbon monoxide and Injury, Myocardial Reperfusion

carbon monoxide has been researched along with Injury, Myocardial Reperfusion in 30 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Research Excerpts

ExcerptRelevanceReference
"Heme oxygenase-1 (HO-1)-dependent carbon monoxide (CO) production related to reperfusion-induced ventricular fibrillation (VF) was studied in HO-1 wild-type (+/+), heterozygous (+/-), and homozygous (-/-) isolated ischemic/reperfused mouse heart."7.72Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. ( Bacskay, I; Bak, I; Balla, J; Das, DK; de Leiris, J; Der, P; Joo, F; Juhasz, B; Kovacs, P; Papp, G; Szendrei, L; Tosaki, A; Turoczi, T; Varga, E, 2003)
"We investigated the pre-clinical utility of carbon monoxide form of PEGylated hemoglobin (PEG-Hb also named SANGUINATE(™)) in myocardial infarction (MI) and in particular the response of diabetic tissues to superimposed ischemia/reperfusion injury."3.79Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia/reperfusion injury in diabetic and normal mice. ( Abuchowski, A; Ananthakrishnan, R; Li, Q; O'Shea, KM; Quadri, N; Ramasamy, R; Schmidt, AM; Wang, L, 2013)
"Heme oxygenase-1 (HO-1)-dependent carbon monoxide (CO) production related to reperfusion-induced ventricular fibrillation (VF) was studied in HO-1 wild-type (+/+), heterozygous (+/-), and homozygous (-/-) isolated ischemic/reperfused mouse heart."3.72Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. ( Bacskay, I; Bak, I; Balla, J; Das, DK; de Leiris, J; Der, P; Joo, F; Juhasz, B; Kovacs, P; Papp, G; Szendrei, L; Tosaki, A; Turoczi, T; Varga, E, 2003)
"Hydrogen treatment alone significantly reduced malondialdehyde levels and serum high-mobility group box 1 protein levels as compared with air-treated controls."1.36Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. ( Billiar, TR; Buchholz, BM; Cardinal, JS; Kaczorowski, DJ; Lee, S; McCurry, KR; Nakao, A; Sugimoto, R; Tobita, K; Toyoda, Y; Wang, Y, 2010)
"Carbon monoxide (CO) carriers have been recently developed as a pharmacological tool to simulate the effect of heme oxygenase-1-derived CO."1.34Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery. ( Bacskay, I; Bak, I; Foresti, R; Gesztelyi, R; Juhasz, B; Lekli, I; Motterlini, R; Szabo, G; Szendrei, L; Tosaki, A; Varadi, J; Varga, E, 2007)

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (40.00)29.6817
2010's13 (43.33)24.3611
2020's5 (16.67)2.80

Authors

AuthorsStudies
Zhang, P1
Yu, Y1
Wang, P1
Shen, H1
Ling, X1
Xue, X1
Yang, Q1
Zhang, Y2
Xiao, J1
Wang, Z1
Logan, SM1
Gupta, A1
Wang, A1
Levy, RJ1
Storey, KB1
Nie, H1
Li, S1
Deng, Y1
Zhou, W1
Wu, W1
Xu, X1
Yu, H1
Li, T1
Iqbal, J1
Chamberlain, J1
Alfaidi, M1
Hughes, M1
Alizadeh, T1
Casbolt, H1
Evans, P1
Mann, B1
Motterlini, R5
Francis, S1
Gunn, J1
Kumar, A1
Boovarahan, SR1
Prem, PN1
Ramanathan, M1
Chellappan, DR1
Kurian, GA1
Zhou, Z1
Ma, S1
Liu, J1
Ji, QR1
Cao, CZ1
Li, XN1
Tang, F1
Zhang, W1
Collino, M1
Pini, A1
Mugelli, N1
Mastroianni, R1
Bani, D1
Fantozzi, R1
Papucci, L1
Fazi, M1
Masini, E1
Meyer, G3
André, L3
Kleindienst, A1
Singh, F1
Tanguy, S3
Richard, S3
Obert, P3
Boucher, F3
Jover, B1
Cazorla, O3
Reboul, C3
Penna, C1
Granata, R1
Tocchetti, CG1
Gallo, MP1
Alloatti, G1
Pagliaro, P1
Vandegriff, KD1
Young, MA1
Lohman, J1
Bellelli, A1
Samaja, M1
Malavalli, A1
Winslow, RM1
Burger, D1
Xiang, F1
Hammoud, L1
Lu, X1
Feng, Q1
Yoshida, K1
Zhu, JC1
Shao, JL1
Ma, H1
Wang, JK1
Nakao, A2
Kaczorowski, DJ1
Wang, Y2
Cardinal, JS1
Buchholz, BM1
Sugimoto, R1
Tobita, K1
Lee, S1
Toyoda, Y1
Billiar, TR1
McCurry, KR1
Boissiere, J2
Farah, C2
Lopez-Lauri, F1
Gayrard, S2
Juhasz, B3
Varga, B1
Czompa, A1
Bak, I3
Lekli, I2
Gesztelyi, R2
Zsuga, J1
Kemeny-Beke, A1
Antal, M1
Szendrei, L3
Tosaki, A3
Ahlström, K1
Biber, B1
Åberg, AM1
Abrahamsson, P1
Johansson, G1
Ronquist, G1
Waldenström, A1
Haney, MF1
Schibilsky, D1
Beyersdorf, F1
Goebel, U1
Stein, AB2
Bolli, R2
Dawn, B2
Sanganalmath, SK1
Zhu, Y1
Wang, OL1
Guo, Y2
Xuan, YT1
Maslov, LN1
Mrochek, AG1
Barzakh, EI1
Lishmanov, AIu1
Gorbunov, AS1
Tsibul'nikov, SIu1
Sementsov, AS1
Prokudina, ES1
Ananthakrishnan, R1
Li, Q1
O'Shea, KM1
Quadri, N1
Wang, L1
Abuchowski, A1
Schmidt, AM1
Ramasamy, R1
Turoczi, T1
Papp, G1
Joo, F1
Das, DK1
de Leiris, J1
Der, P1
Varga, E2
Bacskay, I2
Balla, J1
Kovacs, P1
Wu, WJ1
Tan, W1
Zhu, X1
Li, QH1
Akamatsu, Y1
Haga, M1
Tyagi, S1
Yamashita, K1
Graça-Souza, AV1
Ollinger, R1
Czismadia, E1
May, GA1
Ifedigbo, E1
Otterbein, LE2
Bach, FH2
Soares, MP1
Lavitrano, M1
Smolenski, RT1
Musumeci, A1
Maccherini, M1
Slominska, E1
Di Florio, E1
Bracco, A1
Mancini, A1
Stassi, G1
Patti, M1
Giovannoni, R1
Froio, A1
Simeone, F1
Forni, M1
Bacci, ML1
D'Alise, G1
Cozzi, E1
Yacoub, MH1
Calise, F1
Mann, BE1
Foresti, R2
Toyokawa, H1
Abe, M1
Kiyomoto, T1
Nakahira, K1
Choi, AM1
Nalesnik, MA1
Thomson, AW1
Murase, N1
Varadi, J1
Szabo, G1
Mei, DS1
Du, YA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 2 Multi-center, Randomized, Double-blind, Comparator-Controlled Dose Finding Study to Evaluate MP4CO for the Acute Treatment of Vaso-occlusive Crises in Subjects With Sickle Cell Disease[NCT01925001]Phase 20 participants (Actual)Interventional2013-10-31Withdrawn (stopped due to Sangart ceased operations)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

5 reviews available for carbon monoxide and Injury, Myocardial Reperfusion

ArticleYear
Role of Hydrogen Sulfide in Myocardial Ischemia-Reperfusion Injury.
    Journal of cardiovascular pharmacology, 2021, 02-01, Volume: 77, Issue:2

    Topics: Animals; Carbon Monoxide; Cardiovascular System; Cell Death; Gasotransmitters; Humans; Hydrogen Sulf

2021
Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.
    Current drug targets, 2015, Volume: 16, Issue:8

    Topics: Animals; Carbon Monoxide; Cardiotonic Agents; Gasotransmitters; Humans; Hydrogen Sulfide; Ischemic P

2015
Pursuing enigmas on ischemic heart disease and sudden cardiac death.
    Legal medicine (Tokyo, Japan), 2009, Volume: 11, Issue:2

    Topics: Animals; Ankyrins; Calcium; Calpain; Carbon Monoxide; Carrier Proteins; Central Nervous System Stimu

2009
[Trigger mechanism of adaptive phenomenon of ischemic heart postconditioning].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2012, Volume: 98, Issue:9

    Topics: Adaptation, Physiological; Analgesics, Opioid; Animals; Biological Factors; Carbon Monoxide; Heart;

2012
Therapeutic applications of carbon monoxide-releasing molecules.
    Expert opinion on investigational drugs, 2005, Volume: 14, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Heme Oxygen

2005

Other Studies

25 other studies available for carbon monoxide and Injury, Myocardial Reperfusion

ArticleYear
Isoflurane and low-level carbon monoxide exposures increase expression of pro-survival miRNA in neonatal mouse heart.
    Cell stress & chaperones, 2021, Volume: 26, Issue:3

    Topics: Animals; Animals, Newborn; Apoptosis; Carbon Monoxide; Gene Expression; Heart; Isoflurane; Mice, Inb

2021
Carbon Monoxide-Saturated Polymerized Placenta Hemoglobin Optimizes Mitochondrial Function and Protects Heart Against Ischemia-Reperfusion Injury.
    Journal of cardiovascular pharmacology, 2021, 06-01, Volume: 77, Issue:6

    Topics: Animals; Carbon Monoxide; Female; Hemoglobins; Humans; Insulin; Male; Mitochondria, Heart; Myocardia

2021
Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
    Journal of cardiovascular pharmacology, 2021, 11-01, Volume: 78, Issue:5

    Topics: Animals; Apoptosis; Biomarkers; Boranes; Carbon Monoxide; Carbonates; Cardiovascular Agents; Caspase

2021
Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia-reperfusion injury in ovariectomized female rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:10

    Topics: Animals; Carbon Monoxide; Cardiotonic Agents; Female; Hemodynamics; Membrane Potential, Mitochondria

2021
[Protective effects of endogenous carbon monoxide against myocardial ischemia-reperfusion injury in rats].
    Sheng li xue bao : [Acta physiologica Sinica], 2018, Apr-25, Volume: 70, Issue:2

    Topics: Animals; Carbon Monoxide; Creatine Kinase; Cyclic GMP; Heart; L-Lactate Dehydrogenase; Myocardial Re

2018
Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failure.
    Disease models & mechanisms, 2013, Volume: 6, Issue:4

    Topics: Animals; Apoptosis; Biomarkers; Carbon Monoxide; Disease Models, Animal; DNA Damage; Enzyme Activati

2013
Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion.
    American journal of physiology. Heart and circulatory physiology, 2015, Apr-01, Volume: 308, Issue:7

    Topics: Air Pollutants; Animals; Antioxidants; Carbon Monoxide; Disease Models, Animal; Enzyme Inhibitors; E

2015
CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats.
    British journal of pharmacology, 2008, Volume: 154, Issue:8

    Topics: Animals; Carbon Monoxide; Disease Models, Animal; Drug Stability; Erythrocytes; Hemoglobins; Male; M

2008
Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 296, Issue:1

    Topics: Animals; Animals, Newborn; Apoptosis; Carbon Monoxide; Cardiotonic Agents; Caspase 3; Caspase 9; Cel

2009
[Interaction between endogenous cystathionine synthase/hydrogen sulfide and heme oxygenase-1/carbon monoxide systems during myocardial ischemic-reperfusion: experiment with rats].
    Zhonghua yi xue za zhi, 2008, Dec-09, Volume: 88, Issue:45

    Topics: Animals; Carbon Monoxide; Cystathionine beta-Synthase; Disease Models, Animal; Heme Oxygenase (Decyc

2008
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:5

    Topics: Administration, Inhalation; Animals; Apoptosis; Blotting, Western; Carbon Monoxide; Cold Ischemia; D

2010
Simulated urban carbon monoxide air pollution exacerbates rat heart ischemia-reperfusion injury.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 298, Issue:5

    Topics: Air Pollutants; Air Pollution; Animals; Antioxidants; Arrhythmias, Cardiac; Calcium; Carbon Monoxide

2010
Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium.
    Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:9

    Topics: Animals; Calcium; Carbon Monoxide; Chromatography, Gas; Heart Function Tests; Heme Oxygenase-1; Male

2011
Exogenous carbon monoxide does not affect cell membrane energy availability assessed by sarcolemmal calcium fluxes during myocardial ischaemia-reperfusion in the pig.
    European journal of anaesthesiology, 2011, Volume: 28, Issue:5

    Topics: Animals; Calcium; Carbon Monoxide; Cell Membrane; Coronary Occlusion; Energy Metabolism; Glucose; Is

2011
Re: Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:12

    Topics: Administration, Inhalation; Animals; Apoptosis; Carbon Monoxide; Cold Ischemia; Drug Therapy, Combin

2010
Moderate exercise prevents impaired Ca2+ handling in heart of CO-exposed rat: implication for sensitivity to ischemia-reperfusion.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:6

    Topics: Air Pollutants; Animals; Antioxidants; Calcium Signaling; Carbon Monoxide; Catalase; Cell Death; Glu

2010
Carbon monoxide induces a late preconditioning-mimetic cardioprotective and antiapoptotic milieu in the myocardium.
    Journal of molecular and cellular cardiology, 2012, Volume: 52, Issue:1

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Carbon Monoxide; Cyclooxygenase 2; Heme Oxygenase

2012
Carbon monoxide form of PEGylated hemoglobin protects myocardium against ischemia/reperfusion injury in diabetic and normal mice.
    Artificial cells, nanomedicine, and biotechnology, 2013, Volume: 41, Issue:6

    Topics: Animals; Biomarkers; Blood Substitutes; Carbon Monoxide; Diabetes Complications; Energy Metabolism;

2013
Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:14

    Topics: Animals; Carbon Monoxide; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Immunohistochemistry; Memb

2003
Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:5

    Topics: Animals; Body Temperature; Carbon Monoxide; Carboxyhemoglobin; Cardiotonic Agents; Drug Administrati

2004
Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:6

    Topics: Animals; Apoptosis; Carbon Monoxide; Heart Transplantation; Heme Oxygenase (Decyclizing); Heme Oxyge

2004
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:10

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apoptosis; Carbon M

2004
Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.
    Transplantation, 2006, Jan-27, Volume: 81, Issue:2

    Topics: Administration, Inhalation; Animals; Base Sequence; Carbon Monoxide; Cytokines; DNA; Graft Survival;

2006
Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
    Life sciences, 2007, Apr-03, Volume: 80, Issue:17

    Topics: Animals; Calcium; Carbon Monoxide; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; Hear

2007
[Cardioprotection and mechanisms of exogenous carbon monoxide releaser CORM-2 against ischemia/reperfusion injury in isolated rat hearts].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2007, Volume: 36, Issue:3

    Topics: Animals; Carbon Monoxide; Cardiotonic Agents; Enzyme Inhibitors; In Vitro Techniques; Male; Myocardi

2007